develop
vaccin
strategi
emerg
pathogen
particularli
challeng
sudden
natur
emerg
virus
long
process
need
tradit
vaccin
develop
therefor
need
develop
rapid
method
vaccin
develop
respond
emerg
pathogen
short
time
frame
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
merscov
late
demonstr
import
coronavirus
emerg
pathogen
spike
glycoprotein
coronavirus
resid
surfac
virion
respons
viru
entri
spike
glycoprotein
major
immunodomin
antigen
coronavirus
proven
excel
target
vaccin
design
seek
block
coronaviru
entri
promot
antibodi
target
infect
cell
vaccin
strategi
coronavirus
involv
live
attenu
viru
recombin
virus
nonrepl
viruslik
particl
express
coronaviru
protein
dna
plasmid
express
coronaviru
gene
none
strategi
progress
approv
human
coronaviru
vaccin
ten
year
sinc
sarscov
emerg
describ
novel
method
gener
merscov
sarscov
fulllength
spike
nanoparticl
combin
adjuv
abl
produc
high
titer
antibodi
mice
coronavirus
infect
rang
mammal
bird
caus
respiratori
tract
infect
gastrointestin
tract
infect
coronavirus
known
caus
sever
therefor
econom
import
diseas
chicken
pig
number
coronavirus
known
infect
human
symptom
usual
mild
healthi
adult
akin
common
cold
rare
caus
sever
pneumonia
howev
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
bat
caus
confirm
infect
result
death
case
link
china
hong
kong
singapor
major
outbreak
outsid
area
occur
toronto
canada
sarscov
zoonot
origin
emerg
bat
via
civet
cat
infect
human
although
report
case
sarscov
infect
human
recent
studi
shown
parent
viru
still
exist
bat
china
late
novel
betacoronaviru
name
middl
east
respiratori
syndrom
coronaviru
merscov
identifi
sampl
sever
respiratori
infect
patient
kingdom
saudi
arabia
ksa
sinc
case
posit
identifi
result
death
wwwwhoorg
case
link
six
countri
near
arabian
peninsula
ksa
jordan
qatar
egypt
oman
unit
arab
emir
case
part
world
notabl
europ
involv
recent
travel
middl
east
region
close
link
peopl
patient
infect
merscov
present
hospit
symptom
consist
sever
lower
respiratori
tract
infect
case
develop
kidney
failur
merscov
close
relat
bat
coronavirus
found
china
europ
africa
suggest
zoonot
origin
similar
sarscov
howev
reservoir
merscov
yet
identifi
coronavirus
envelop
virus
larg
singlestrand
posit
sens
rna
genom
encod
major
structur
protein
spike
membran
envelop
e
nucleocapsid
n
protein
type
transmembran
glycoprotein
express
surfac
coronavirus
respons
receptor
bind
virion
entri
cell
locat
virion
surfac
role
bind
coronaviru
receptor
find
induc
neutral
antibodi
vivo
made
attract
target
vaccin
develop
strategi
previou
effort
creat
vaccin
sarscov
util
number
approach
none
current
licens
use
recent
studi
four
put
sarscov
vaccin
yield
neg
result
initi
studi
suggest
whole
inactiv
sarscov
could
use
effect
vaccin
howev
work
suggest
level
protect
induc
inactiv
sarscov
incomplet
fail
prevent
sarscov
symptom
also
induc
increas
eosinophilia
vaccin
anim
therefor
like
candid
coronaviru
vaccin
platform
base
spike
subunit
recombin
virus
express
sarscov
protein
dna
plasmid
express
sarscov
protein
viruslik
particl
vlp
base
vaccin
howev
approach
come
safeti
concern
approv
process
current
approv
vaccin
merscov
earli
studi
use
modifi
vaccinia
viru
replic
defici
merscov
shown
induc
antibodi
capabl
neutral
merscov
vitro
ideal
vaccin
highli
pathogen
virus
includ
coronavirus
abl
made
rapidli
demand
conjunct
approv
adjuv
use
approv
techniqu
emerg
sarscov
merscov
highlight
import
coronavirus
potenti
human
pathogen
emerg
time
therefor
rapid
method
treatment
vaccin
requir
import
group
virus
studi
describ
novel
method
creat
sarscov
merscov
nanoparticl
conjunct
adjuv
abl
induc
neutral
antibodi
respons
mice
vero
cell
origin
obtain
american
type
cultur
collect
atcc
maintain
minim
eagl
medium
mem
corn
supplement
heatinactiv
fetal
bovin
serum
fb
safc
lglutamin
gibco
penicillin
streptomycin
gemini
bioproduct
spodoptera
frugiperda
insect
cell
maintain
suspens
cultur
hyqsfx
insect
serum
free
medium
hyclon
logan
ut
mous
adapt
sarscov
previous
describ
grown
larg
volum
passag
vero
cell
store
merscov
jordan
obtain
nih
conjunct
afhscgei
special
assist
dr
mohareb
experi
live
viru
perform
biosafeti
level
condit
univers
maryland
baltimor
merscov
jordan
spike
protein
ident
merscov
al
spike
protein
sequenc
use
nanoparticl
clone
consid
merscov
al
merscov
jordan
homolog
spike
protein
sarscov
urbani
spike
protein
ident
sarscov
spike
protein
sequenc
use
nanoparticl
clone
consid
sarscov
urbani
sarscov
spike
protein
homolog
merscov
protein
sequenc
isol
ncbi
access
sarscov
protein
sequenc
urbani
strain
ncbi
access
gene
codon
optim
optim
express
insect
cell
biochem
synthes
merscov
genscript
piscataway
nj
sarscov
geneart
ag
regensburg
germani
full
length
gene
clone
bamhi
hindiii
site
baculoviru
transfer
vector
plasmid
invitrogen
carlsbad
ca
transcript
control
autographa
californica
multipl
nuclear
polyhedrosi
viru
acmnpv
polyhedrin
promot
recombin
baculoviru
construct
plaqu
purifi
master
seed
stock
prepar
character
ident
use
prepar
work
viru
stock
titer
baculoviru
master
work
stock
determin
use
rapid
titrat
kit
bacpak
baculoviru
rapid
titer
kit
clontech
mountain
view
ca
recombin
baculoviru
stock
prepar
infect
cell
low
multipl
infect
moi
plaqu
form
unit
pfu
per
cell
harvest
hour
post
infect
hpi
merscov
sarscov
protein
antigen
produc
cell
cellsml
infect
specif
recombin
baculoviru
infect
cell
incub
continu
agit
harvest
hpi
centrifug
g
min
protein
extract
cellular
membran
nonion
deterg
insolubl
materi
remov
centrifug
min
protein
oligom
purifi
use
combin
anion
exchang
affin
size
exclus
chromatographi
purif
major
deterg
remov
allow
trimer
form
higher
order
proteinprotein
micellular
nanoparticl
purifi
nanoparticl
micron
filter
store
merscov
sarscov
analyz
sdspage
use
gradient
polyacrylamid
gel
invitrogen
stain
gelcod
blue
stain
reagent
pierc
rockford
il
quantifi
scan
densitometri
use
onedscan
system
bd
bioscienc
rockvil
md
purifi
protein
test
total
protein
concentr
bca
bicinchonin
acid
protein
assay
pierc
biochem
particl
size
dynam
light
scatter
use
zetas
nano
malvern
instrument
pa
use
standard
manufactur
recommend
method
purifi
merscov
sarscov
protein
adsorb
flotat
minut
onto
freshli
discharg
carbon
parlodionco
copper
grid
polysci
warrington
pa
grid
rins
buffer
contain
tri
ph
kcl
neg
stain
phosphotungst
acid
dri
aspir
viruslik
particl
visual
hitachi
transmiss
electron
microscop
hitachi
high
technolog
america
schaumburg
il
oper
kv
digit
captur
ccd
camera
resolut
advanc
microscopi
techniqu
corp
danver
immunogen
purifi
merscov
sarscov
protein
nanoparticl
evalu
balbc
mice
week
old
purchas
harlan
laboratori
inc
fredrick
md
mice
per
group
receiv
vaccin
intramuscular
inject
quadricep
muscl
day
mice
immun
merscov
protein
receiv
either
protein
alon
merscov
protein
either
aluminum
hydroxid
alhydrogel
brenntag
ag
matrix
isconova
sweden
mice
immun
sarscov
protein
receiv
protein
alon
protein
either
aluminum
hydroxid
alum
matrix
sera
collect
day
serolog
analysi
blood
collect
via
retroorbit
rout
serum
obtain
centrifug
whole
blood
anim
procedur
accord
nrc
guid
care
use
laboratori
anim
anim
welfar
act
cdcnih
biosafeti
microbiolog
biomed
laboratori
mous
sera
dilut
vero
cell
growth
media
dilut
twofold
seri
merscovjordan
sarscov
ad
final
concentr
tcid
ml
incub
minut
room
temperatur
mock
infect
mous
sera
merscovjordan
sarscov
vero
media
serv
neg
posit
control
respect
inhibitori
capac
serum
dilut
assess
tcid
assay
serum
dilut
merscovjordan
sarscov
inhibit
record
geometr
mean
titer
gmt
group
mice
calcul
present
confid
interv
ci
vero
cell
seed
plate
usa
scientif
cell
per
well
cultur
overnight
cell
infect
dilut
seri
viru
contain
media
triplic
cultur
hour
plate
fix
paraformaldehyd
sigma
aldrich
minut
room
temperatur
stain
crystal
violet
sigma
aldrich
methanol
sigma
aldrich
minut
room
temperatur
plate
wash
twice
water
cell
death
assess
presenc
live
cell
absenc
dead
cell
crystal
violet
stain
viral
load
calcul
base
dilut
media
kill
cell
use
tcid
formula
neutral
titer
analyz
use
nonparametr
oneway
anova
statist
signific
assum
p
fulllength
recombin
mer
sar
protein
produc
baculoviru
insect
cell
express
system
protein
extract
infect
cell
pellet
nonion
deterg
purifi
column
chromatographi
previous
describ
purifi
fulllength
mer
sar
protein
appar
molecular
weight
kda
kda
sdspage
respect
figur
purifi
mer
sar
protein
form
nm
diamet
particl
consist
multipl
protein
molecul
observ
electron
microscopi
figur
dynam
light
scatter
data
shown
vaccin
develop
effect
vaccin
strong
neutral
respons
target
ie
dilut
antibodi
effect
neutral
viru
high
experi
mice
per
group
inocul
merscov
sarscov
protein
serum
test
homolog
viru
previou
work
shown
product
protect
neutral
antibodi
respons
mice
inocul
chimer
sarscov
nanoparticl
combin
alum
adjuv
studi
also
use
matrix
adjuv
assess
induct
neutral
antibodi
respons
mice
sarscov
protein
use
without
adjuv
neutral
antibodi
concentr
sera
day
postinocul
low
gmt
chang
day
postinocul
gmt
indic
sarscov
protein
without
adjuv
effect
induc
antisarscov
neutral
antibodi
tabl
figur
alum
use
adjuv
conjunct
sarscov
protein
statist
signific
fold
increas
neutral
antibodi
exampl
day
postinocul
gmt
p
matrix
adjuv
use
conjunct
sarscov
statist
signific
fold
increas
neutral
antibodi
exampl
day
postinocul
gmt
p
indic
matrix
effect
adjuv
alum
none
vaccin
sarscov
show
signific
differ
neutral
antibodi
titer
day
postinocul
compar
day
postinocul
suggest
neutral
antibodi
respons
chang
vaccin
cours
data
confirm
previou
observ
alum
significantli
enhanc
product
antisarscov
neutral
antibodi
mice
also
demonstr
matrix
adjuv
effect
induc
antisarscov
neutral
antibodi
respons
mice
suggest
matrix
use
effect
vaccin
adjuv
sarscov
merscov
inocul
balbc
mice
without
adjuv
level
neutral
antibodi
merscov
jordan
day
postinocul
low
exampl
gmt
data
demonstr
inocul
merscov
protein
alon
effect
method
develop
robust
neutral
antibodi
respons
day
postinocul
without
adjuv
level
neutral
merscovjordan
fold
higher
day
statist
signific
exampl
merss
gmt
p
amount
merss
protein
significantli
effect
gmt
neutral
respons
trend
consist
respons
higher
dose
merss
adjuv
alum
use
conjunct
merscov
inocul
level
neutral
antibodi
day
postinocul
significantli
higher
found
sera
mice
inocul
merss
alon
exampl
merss
alon
gmt
compar
merss
alum
gmt
p
indic
alum
promot
product
antimerscov
neutral
antibodi
signific
differ
dose
regimen
consist
merscov
merscov
presenc
alum
exampl
day
merss
plu
alum
gmt
compar
merss
plu
alum
gmt
p
suggest
lower
dose
merss
use
effect
vaccin
presenc
alum
furthermor
signific
differ
neutral
antibodi
sera
day
compar
day
exampl
merss
plu
alum
day
gmt
compar
day
gmt
p
indic
presenc
alum
vaccin
cours
caus
earli
product
neutral
antibodi
maintain
matrix
adjuv
use
conjunct
merscov
inocul
increas
level
neutral
antibodi
day
postinocul
significantli
higher
compar
sera
mice
inocul
merss
alon
fold
fold
higher
sera
mice
inocul
merss
plu
alum
exampl
merss
alon
gmt
compar
merss
alum
gmt
compar
merss
matrix
gmt
p
indic
matrix
promot
product
antimerscov
neutral
antibodi
higher
seen
alum
use
adjuv
signific
differ
dose
mice
merscov
merscov
presenc
matrix
exampl
day
merss
plu
matrix
gmt
compar
merss
plu
matrix
gmt
p
suggest
lower
dose
merss
use
effect
vaccin
presenc
matrix
furthermor
signific
differ
neutral
antibodi
sera
day
compar
day
exampl
merss
plu
matrix
day
gmt
compar
day
gmt
p
suggest
presenc
matrix
vaccin
cours
caus
earli
product
neutral
antibodi
maintain
data
demonstr
merss
vaccin
platform
use
induc
neutral
antibodi
respons
mice
also
demonstr
matrix
adjuv
significantli
enhanc
level
neutral
antibodi
produc
compar
alum
determin
crossneutr
sarscov
antisera
merscov
infect
vice
versa
test
sera
offer
strong
protect
homolog
viru
heterolog
viru
therefor
sera
mice
inocul
merss
sarss
combin
matrix
adjuv
test
sarscov
merscov
respect
sera
mice
inocul
merss
combin
matrix
unabl
neutral
sarscov
none
dilut
test
effect
titer
sarscov
sera
mice
inocul
sarss
combin
matrix
minim
abl
neutral
merscov
background
mice
show
low
level
neutral
effect
merscov
none
show
complet
neutral
neutral
much
lower
extent
antisarscov
sera
sarscov
antimerscov
sera
merscov
data
shown
data
demonstr
limit
crossprotect
mous
sera
contain
neutral
antibodi
induc
merss
sarss
need
vaccin
product
rapid
process
manufactur
vaccin
emerg
pathogen
recent
emerg
sarscov
merscov
demonstr
import
coronavirida
viru
famili
import
group
emerg
pathogen
previou
effort
develop
vaccin
sarscov
encompass
mani
method
yield
variabl
result
studi
describ
novel
method
develop
protein
nanoparticl
carri
spike
protein
sarscov
merscov
abl
induc
signific
neutral
antibodi
respons
mice
nanoparticl
contain
merss
sarss
potenti
immunogen
viral
insect
protein
format
amphiphil
membran
protein
aggreg
protein
nanoparticl
use
studi
rel
homogen
size
solubl
aqueou
media
use
platform
vaccin
first
describ
simon
et
al
recent
respiratori
syncyti
viru
rsv
fusion
f
glycoprotein
nanoparticl
vaccin
shown
highli
immunogen
induc
protect
immun
respons
conform
epitop
phase
human
studi
rsv
f
nanoparticl
vaccin
well
toler
induc
neutral
antibodi
level
associ
decreas
hospit
rsv
children
shown
mice
vaccin
coronaviru
nanoparticl
produc
high
level
neutral
antibodi
homolog
viru
offer
crossprotect
heterolog
viru
data
suggest
coronaviru
nanoparticl
abl
elicit
specif
antisarscov
merscov
antibodi
respons
mice
gener
anticoronaviru
respons
use
protect
multipl
coronavirus
given
far
one
coronaviru
emerg
time
suffici
work
determin
nanoparticl
vaccin
use
combin
also
investig
use
adjuv
boost
product
neutral
antibodi
coronaviru
use
alum
matrix
neutral
antibodi
level
significantli
boost
fold
alum
fold
matrix
level
neutral
antibodi
produc
nanoparticl
alon
alum
common
adjuv
use
previous
boost
neutral
antibodi
sarscov
vlp
vaccin
strategi
show
alum
also
significantli
boost
respons
sarscov
nanoparticl
also
merscov
nanoparticl
mice
matrix
saponin
base
adjuv
manufactur
novavax
ab
formal
isconova
ab
uppsala
sweden
quillaja
saponin
extract
bark
tree
quillaja
saponaria
molina
two
fraction
c
independ
formul
phospholipid
cholesterol
creat
matrix
particl
nm
cage
like
structur
matrix
compris
two
compon
matrixa
matrixc
ratio
shown
potent
adjuv
clinic
trial
data
studi
demonstr
matrix
effect
alum
boost
neutral
antibodi
respons
coronaviru
nanoparticl
mice
especi
merscov
spike
studi
need
determin
coronaviru
nanoparticl
vaccin
block
coronaviru
replic
pathogenesi
vivo
anim
model
develop
small
anim
model
current
exist
merscov
replic
mice
ferret
hamster
demonstr
coronaviru
nanoparticl
abl
stimul
neutral
antibodi
respons
mice
import
first
step
toward
vaccin
develop
serum
mice
vaccin
note
mix
spike
protein
adjuv
analyz
assay
neutral
capabl
geometr
mean
titer
gmt
graph
group
mice
per
group
error
bar
indic
confid
interv
star
denot
statist
signific
differ
p
note
text
describ
materi
method
